Primary nasal tuberculosis during anti-tumour necrosis factor alpha treatment of a patient with rheumatoid arthritis

被引：3

作者：

Ribeiro, Sofia ^{[1
]}

Ferreira, Betania ^{[1
]}

Duarte, Raquel

Almeida, Isabel ^{[1
,2
]}

Vasconcelos, Carlos ^{[2
]}

机构：

[1] Ctr Hosp Porto, Dept Internal Med, Hosp Santo Antonio, Oporto, Portugal

[2] Ctr Hosp Porto, Unidade Imunol Clin, Hosp Santo Antonio, Oporto, Portugal

来源：

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2013年 / 45卷 / 12期

关键词：

Nasal tuberculosis; anti-tumour necrosis factor alpha; rheumatoid arthritis; INFECTION; DISEASE; ENTITY; RISK;

D O I：

10.3109/00365548.2013.818246

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Anti-tumour necrosis factor alpha (anti-TNF alpha) therapy is increasingly used in several inflammatory disease processes, including rheumatoid arthritis. However it has a significant potential for adverse events, such as reactivation of latent tuberculosis, which is frequently found in disseminated or extrapulmonary forms. We present a rare case of primary nasal tuberculosis within the context of anti-TNF alpha therapy for rheumatoid arthritis. To our knowledge, this is the first reported case of primary nasal tuberculosis in a patient with rheumatoid arthritis receiving anti-TNF alpha therapy.

引用

页码：957 / 960

页数：4

共 50 条

[1] Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis
Hishitani, Y.
Ogata, A.
Shima, Y.
Hirano, T.
Ebina, K.
Kunugiza, Y.
Shi, K.
Narazaki, M.
Hagihara, K.
Tomita, T.
Yoshikawa, H.
Tanaka, T.
Kumanogoh, A.
[J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (04) : 253 - 259
[2] Peptostreptococcal pericarditis complicating anti-tumour necrosis factor α treatment in rheumatoid arthritis
Harney, S
O'Shea, FD
FitzGerald, O
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (07) : 653 - 654
[3] Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis
Rajakulendran, S.
Gadsby, K.
Allen, D.
O'Reilly, S.
Deighton, C.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (12) : 1678 - 1679
[4] AN EXPLORATION OF RHEUMATOID ARTHRITIS PATIENT'S EXPERIENCE OF ANTI-TUMOUR NECROSIS FACTOR (ANTI-TNF) TREATMENT
Edwards, J.
[J]. RHEUMATOLOGY, 2003, 42 : 152 - 152
[5] An exploration of rheumatoid arthritis patient's experience of anti-tumour necrosis factor (anti-TNF) treatment
Edwards, J
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 557 - 558
[6] The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
Askling, Johan
Dixon, Will
[J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 138 - 144
[7] Salmonella enterica Arthritis in a Patient with Rheumatoid Arthritis Receiving Anti-tumour Necrosis Factor Therapy
Bubonja-Sonje, M.
Rubinic, D.
Anic, F.
Novak, S.
Vuckovic, D.
Abram, M.
[J]. WEST INDIAN MEDICAL JOURNAL, 2013, 62 (03): : 270 - 272
[8] Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
Cavazzana, I.
Franceschini, F.
Danieli, E.
Airo, P.
Cattaneo, R.
[J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S13 - S13
[9] Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
I Cavazzana
F Franceschini
E Danieli
P Airò
R Cattaneo
[J]. Arthritis Research & Therapy, 7
[10] Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis
Iagnocco, Annamaria
Finucci, Annacarla
Ceccarelli, Fulvia
Perricone, Carlo
Iorgoveanu, Vasilia
Valesini, Guido
[J]. RHEUMATOLOGY, 2015, 54 (10) : 1890 - 1896

← 1 2 3 4 5 →